Skip to main content
Erschienen in: Clinical Rheumatology 12/2018

31.08.2018 | Original Article

Evaluation of plasma microRNA expressions in patients with juvenile idiopathic arthritis

verfasst von: Ferhat Demir, Alper Han Çebi, Mukaddes Kalyoncu

Erschienen in: Clinical Rheumatology | Ausgabe 12/2018

Einloggen, um Zugang zu erhalten

Abstract

Juvenile idiopathic arthritis (JIA) is the most common chronic rheumatic disease of childhood, yet its etiology is unknown. It is known that microribonucleic acids (miRNAs) play a role in immunoregulation. We aimed to evaluate the plasma expression of some candidate miRNAs that are associated with the pathogenesis of autoimmunity. Thirty-one patients diagnosed with JIA and age-sex-matched 31 healthy children were enrolled for the study. The plasma levels of four candidate miRNAs (miRNA-16, miRNA-155, miRNA-204, and miRNA-451), which are known to be associated with autoimmunity, were examined in all the subjects. The plasma levels of miRNAs were measured with real-time PCR in the patients in active and inactive periods and in the healthy controls. The groups were compared with each other. The plasma miRNA-155 levels were found to increase in the JIA patients compared to the healthy controls, and it was statistically more significant in the inactive period. We found that the JIA patients had the higher levels of miRNA-16 and the lower levels of miRNA-204/miRNA-451 expressions compare with the control group, but there was no statistically significant difference. A statistically significant decrease in the plasma levels of miRNA-204 was found in the patients that were in inactive disease with only methotrexate therapy. The plasma miRNA expressions were compared in the JIA subtypes, and it was observed that miRNA-204 levels were higher in polyarticular JIA and miRNA-451 levels were higher in enthesitis-related arthritis without statistical significance. The significant alterations in the plasma expression of miRNA-155 and miRNA-204 suggest to us that these molecules may be related to the pathogenesis of JIA. More comprehensive and functional researches about the role of these molecules are needed in this regard.
Literatur
1.
Zurück zum Zitat Cassidy JT, Petty RE (2011) Chronic arthritis in childhood. In: Cassidy JT, Petty RE, Laxer RM, Lindsley CB (eds) Textbook of pediatric rheumatology, 6th edn. Elsevier Inc, Philadelphia, pp 211–235 Cassidy JT, Petty RE (2011) Chronic arthritis in childhood. In: Cassidy JT, Petty RE, Laxer RM, Lindsley CB (eds) Textbook of pediatric rheumatology, 6th edn. Elsevier Inc, Philadelphia, pp 211–235
2.
Zurück zum Zitat Jarvis JN, Jiang K, Frank MB, Knowlton N, Aggarwal A, Wallace CA, McKee R, Chaser B, Tung C, Smith LB, McGhee JL, Chen Y, Osban J, O’Neil KM, Centola M (2009) Gene expression profiling in neutrophils from children with polyarticular juvenile idiopathic arthritis. Arthritis Rheum 60:1488–1495CrossRef Jarvis JN, Jiang K, Frank MB, Knowlton N, Aggarwal A, Wallace CA, McKee R, Chaser B, Tung C, Smith LB, McGhee JL, Chen Y, Osban J, O’Neil KM, Centola M (2009) Gene expression profiling in neutrophils from children with polyarticular juvenile idiopathic arthritis. Arthritis Rheum 60:1488–1495CrossRef
3.
Zurück zum Zitat Lin YT, Wang CT, Gershwin ME, Chiang BL (2011) The pathogenesis of oligoarticular/polyarticular vs systemic juvenile idiopathic arthritis. Autoimmun Rev 10:482–489CrossRef Lin YT, Wang CT, Gershwin ME, Chiang BL (2011) The pathogenesis of oligoarticular/polyarticular vs systemic juvenile idiopathic arthritis. Autoimmun Rev 10:482–489CrossRef
4.
Zurück zum Zitat Kasapçopur Ö, Arısoy N (2003) Jüvenil idyopatik artrit. Türk Pediatri Arşivi 38:8–19 Kasapçopur Ö, Arısoy N (2003) Jüvenil idyopatik artrit. Türk Pediatri Arşivi 38:8–19
6.
Zurück zum Zitat Raponi M, Dossey L, Jatkoe T, Wu X, Chen G, Fan H, Beer DG (2009) Micro RNA classifiers for predicting prognosis of squamous cell lung cancer. Cancer Res 69:5776–5783CrossRef Raponi M, Dossey L, Jatkoe T, Wu X, Chen G, Fan H, Beer DG (2009) Micro RNA classifiers for predicting prognosis of squamous cell lung cancer. Cancer Res 69:5776–5783CrossRef
7.
Zurück zum Zitat Yu SL, Chen HY, Chang GC, Chen CY, Chen HW, Singh S, Cheng CL, Yu CJ, Lee YC, Chen HS, Su TJ, Chiang CC, Li HN, Hong QS, Su HY, Chen CC, Chen WJ, Liu CC, Chan WK, Chen WJ, Li KC, Chen JJW, Yang PC (2008) MicroRNA signature predicts survival and relapse in lung cancer. Cancer Cell 13:48–57CrossRef Yu SL, Chen HY, Chang GC, Chen CY, Chen HW, Singh S, Cheng CL, Yu CJ, Lee YC, Chen HS, Su TJ, Chiang CC, Li HN, Hong QS, Su HY, Chen CC, Chen WJ, Liu CC, Chan WK, Chen WJ, Li KC, Chen JJW, Yang PC (2008) MicroRNA signature predicts survival and relapse in lung cancer. Cancer Cell 13:48–57CrossRef
8.
Zurück zum Zitat Ventura A, Jacks T (2009) MicroRNAs and cancer: short RNAs go a long way. Cell 136:586–591CrossRef Ventura A, Jacks T (2009) MicroRNAs and cancer: short RNAs go a long way. Cell 136:586–591CrossRef
9.
Zurück zum Zitat Ceribelli A, Yao B, Dominguez-Gutierrez PR et al (2011) MicroRNAs in systemic rheumatic diseases. Arthritis Res Ther 13:229CrossRef Ceribelli A, Yao B, Dominguez-Gutierrez PR et al (2011) MicroRNAs in systemic rheumatic diseases. Arthritis Res Ther 13:229CrossRef
10.
Zurück zum Zitat Contreras J, Rao DS (2012) MicroRNAs in inflammation and immune responses. Leukemia 26:404–413CrossRef Contreras J, Rao DS (2012) MicroRNAs in inflammation and immune responses. Leukemia 26:404–413CrossRef
11.
Zurück zum Zitat Carissimi C, Fulci V, Macino G (2009) MicroRNAs: novel regulators of immunity. Autoimmun Rev 8:520–524CrossRef Carissimi C, Fulci V, Macino G (2009) MicroRNAs: novel regulators of immunity. Autoimmun Rev 8:520–524CrossRef
12.
Zurück zum Zitat Singh RP, Massachi I, Manickavel S, Singh S, Rao NP, Hasan S, Mc Curdy DK, Sharma S, Wong D, Hahn BH, Rehimi H (2013) The role of miRNA in inflammation and autoimmunity. Autoimmun Rev 12:1160–1165CrossRef Singh RP, Massachi I, Manickavel S, Singh S, Rao NP, Hasan S, Mc Curdy DK, Sharma S, Wong D, Hahn BH, Rehimi H (2013) The role of miRNA in inflammation and autoimmunity. Autoimmun Rev 12:1160–1165CrossRef
13.
Zurück zum Zitat Pauley KM, Satoh M, Chan AL et al (2008) Upregulated miR-146a expression in peripheral blood mononuclear cells from rheumatoid arthritis patients. Arthritis Res Ther 10:101CrossRef Pauley KM, Satoh M, Chan AL et al (2008) Upregulated miR-146a expression in peripheral blood mononuclear cells from rheumatoid arthritis patients. Arthritis Res Ther 10:101CrossRef
14.
Zurück zum Zitat Hu Z, Jiang K, Frank MB, Chen Y, Jarvis JN (2016) Complexity and specificity of the neutrophil transcriptomes in juvenile idiopathic arthritis. Sci Rep 6:27453CrossRef Hu Z, Jiang K, Frank MB, Chen Y, Jarvis JN (2016) Complexity and specificity of the neutrophil transcriptomes in juvenile idiopathic arthritis. Sci Rep 6:27453CrossRef
15.
Zurück zum Zitat Stanczyk J, Pedrioli DM, Brentano F et al (2008) Altered expression of MicroRNA in synovial fibroblasts and synovial tissue in rheumatoid arthritis. Arthritis Rheum 58:1001–1009CrossRef Stanczyk J, Pedrioli DM, Brentano F et al (2008) Altered expression of MicroRNA in synovial fibroblasts and synovial tissue in rheumatoid arthritis. Arthritis Rheum 58:1001–1009CrossRef
16.
Zurück zum Zitat Kurowska-Stolarska M, Alivernini S, Ballantine LE, Asquith DL, Millar NL, Gilchrist DS, Reilly J, Ierna M, Fraser AR, Stolarski B, McSharry C, Hueber AJ, Baxter D, Hunter J, Gay S, Liew FY, McInnes IB (2011) MicroRNA-155 as a proinflammatory regulator in clinical and experimental arthritis. Proc Natl Acad Sci U S A 108:11193–11198CrossRef Kurowska-Stolarska M, Alivernini S, Ballantine LE, Asquith DL, Millar NL, Gilchrist DS, Reilly J, Ierna M, Fraser AR, Stolarski B, McSharry C, Hueber AJ, Baxter D, Hunter J, Gay S, Liew FY, McInnes IB (2011) MicroRNA-155 as a proinflammatory regulator in clinical and experimental arthritis. Proc Natl Acad Sci U S A 108:11193–11198CrossRef
17.
Zurück zum Zitat Naraparaju K, Kolla V, Zhuang T, Higashi M, Iyer R, Kolla S, Okawa ER, Blobel GA, Brodeur GM (2016) Role of microRNAs in epigenetic silencing of the CHD5 tumor suppressor gene in neuroblastomas. Oncotarget 7:15977–15985CrossRef Naraparaju K, Kolla V, Zhuang T, Higashi M, Iyer R, Kolla S, Okawa ER, Blobel GA, Brodeur GM (2016) Role of microRNAs in epigenetic silencing of the CHD5 tumor suppressor gene in neuroblastomas. Oncotarget 7:15977–15985CrossRef
18.
Zurück zum Zitat Butrym A, Rybka J, Baczyńska D, Tukiendorf A, Kuliczkowski K, Mazur G (2015) Low expression of microRNA-204 (miR-204) is associated with poor clinical outcome of acute myeloid leukemia (AML) patients. J Exp Clin Cancer Res 34:68CrossRef Butrym A, Rybka J, Baczyńska D, Tukiendorf A, Kuliczkowski K, Mazur G (2015) Low expression of microRNA-204 (miR-204) is associated with poor clinical outcome of acute myeloid leukemia (AML) patients. J Exp Clin Cancer Res 34:68CrossRef
19.
Zurück zum Zitat Ma L, Deng X, Wu M, Zhang G, Huang J (2014) Down-regulation of miRNA-204 by LMP-1enhances CDC42 activity and facilitates invasion of EBV-associated nasopharyngeal carcinoma cells. FEBS Lett 588:1562–1570CrossRef Ma L, Deng X, Wu M, Zhang G, Huang J (2014) Down-regulation of miRNA-204 by LMP-1enhances CDC42 activity and facilitates invasion of EBV-associated nasopharyngeal carcinoma cells. FEBS Lett 588:1562–1570CrossRef
20.
Zurück zum Zitat Li K, Xyu Q, Liu X, Liu Q, Wang M (2015) Growth inhibition of human hepatocellular carcinoma by miRNA-204 via down-regulation of Bcl-2 and Sirt1 expression. Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi 31:168–172PubMed Li K, Xyu Q, Liu X, Liu Q, Wang M (2015) Growth inhibition of human hepatocellular carcinoma by miRNA-204 via down-regulation of Bcl-2 and Sirt1 expression. Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi 31:168–172PubMed
21.
Zurück zum Zitat Béres NJ, Kiss Z, Sztupinszki Z, Lendvai G, Arató A, Sziksz E, Vannay Á, Szabó AJ, Müller KE, Cseh Á, Boros K, Veres G (2017) Altered mucosal expression of microRNAs in pediatric patients with inflammatory bowel disease. Dig Liver Dis 49:378–387CrossRef Béres NJ, Kiss Z, Sztupinszki Z, Lendvai G, Arató A, Sziksz E, Vannay Á, Szabó AJ, Müller KE, Cseh Á, Boros K, Veres G (2017) Altered mucosal expression of microRNAs in pediatric patients with inflammatory bowel disease. Dig Liver Dis 49:378–387CrossRef
22.
Zurück zum Zitat Lai NS, Yu HC, Tung CH, Huang KY, Huang HB, Lu MC (2017) The role of aberrant expression of T cell miRNAs affected by TNF-α in the immunopathogenesis of rheumatoid arthritis. Arthritis Res Ther 19:261CrossRef Lai NS, Yu HC, Tung CH, Huang KY, Huang HB, Lu MC (2017) The role of aberrant expression of T cell miRNAs affected by TNF-α in the immunopathogenesis of rheumatoid arthritis. Arthritis Res Ther 19:261CrossRef
23.
Zurück zum Zitat Rosenberger CM, Podyminogin RL, Navarro G, Zhao GW, Askovich PS, Weiss MJ, Aderem A (2012) miR-451 regulates dendritic cell cytokine responses to influenza infection. J Immunol 189:5965–5975CrossRef Rosenberger CM, Podyminogin RL, Navarro G, Zhao GW, Askovich PS, Weiss MJ, Aderem A (2012) miR-451 regulates dendritic cell cytokine responses to influenza infection. J Immunol 189:5965–5975CrossRef
24.
Zurück zum Zitat Lucherini OM, Obici L, Ferracin M et al (2013) First report of circulating microRNAs in tumour necrosis factor receptor-associated periodic syndrome (TRAPS). PLoS One 8:73443CrossRef Lucherini OM, Obici L, Ferracin M et al (2013) First report of circulating microRNAs in tumour necrosis factor receptor-associated periodic syndrome (TRAPS). PLoS One 8:73443CrossRef
25.
Zurück zum Zitat Petty RE, Southwood TR, Manners P, Baum J, Glass DN, Goldenberg J, He X, Maldonado-Cocco J, Orozco-Alcala J, Prieur AM, Suarez-Almazor ME, Woo P, International League of Associations for Rheumatology (2004) International League of Associations for Rheumatology classification of juvenile idiopathic arthritis: second revision, Edmonton, 2001. J Rheumatol 31:390–392 Petty RE, Southwood TR, Manners P, Baum J, Glass DN, Goldenberg J, He X, Maldonado-Cocco J, Orozco-Alcala J, Prieur AM, Suarez-Almazor ME, Woo P, International League of Associations for Rheumatology (2004) International League of Associations for Rheumatology classification of juvenile idiopathic arthritis: second revision, Edmonton, 2001. J Rheumatol 31:390–392
26.
Zurück zum Zitat Wallace CA, Giannini EH, Huang B, Itert L, Ruperto N, Childhood Arthritis Rheumatology Research Alliance, Pediatric Rheumatology Collaborative Study Group, Paediatric Rheumatology International Trials Organisation (2011) American College of Rheumatology provisional criteria for defining clinical inactive disease in select categories of juvenile idiopathic arthritis. Arthritis Care Res (Hoboken) 63:929–936CrossRef Wallace CA, Giannini EH, Huang B, Itert L, Ruperto N, Childhood Arthritis Rheumatology Research Alliance, Pediatric Rheumatology Collaborative Study Group, Paediatric Rheumatology International Trials Organisation (2011) American College of Rheumatology provisional criteria for defining clinical inactive disease in select categories of juvenile idiopathic arthritis. Arthritis Care Res (Hoboken) 63:929–936CrossRef
27.
Zurück zum Zitat Sun J, Feng M, Wu F, Ma X, Lu J, Kang M, Liu Z (2016) Plasma miR-26a as a diagnostic biomarker regulates cytokine expression in systemic juvenile idiopathic arthritis. J Rheumatol 43:1607–1614CrossRef Sun J, Feng M, Wu F, Ma X, Lu J, Kang M, Liu Z (2016) Plasma miR-26a as a diagnostic biomarker regulates cytokine expression in systemic juvenile idiopathic arthritis. J Rheumatol 43:1607–1614CrossRef
28.
Zurück zum Zitat Ma X, Wu F, Xin L et al (2015) Differential plasma microRNAs expression in juvenile idiopathic arthritis. Mod Rheumatol 20:1–9 Ma X, Wu F, Xin L et al (2015) Differential plasma microRNAs expression in juvenile idiopathic arthritis. Mod Rheumatol 20:1–9
29.
Zurück zum Zitat Kamiya Y, Kawada J, Kawano Y, Torii Y, Kawabe S, Iwata N, Ito Y (2015) Serum microRNAs as potential biomarkers of juvenile idiopathic arthritis. Clin Rheumatol 34:1705–1712CrossRef Kamiya Y, Kawada J, Kawano Y, Torii Y, Kawabe S, Iwata N, Ito Y (2015) Serum microRNAs as potential biomarkers of juvenile idiopathic arthritis. Clin Rheumatol 34:1705–1712CrossRef
30.
Zurück zum Zitat Li D, Duan M, Feng Y, Geng L, Li X, Zhang W (2016) MiR-146a modulates macrophage polarization in systemic juvenile idiopathic arthritis by targeting INHBA. Mol Immunol 77:205–212CrossRef Li D, Duan M, Feng Y, Geng L, Li X, Zhang W (2016) MiR-146a modulates macrophage polarization in systemic juvenile idiopathic arthritis by targeting INHBA. Mol Immunol 77:205–212CrossRef
32.
Zurück zum Zitat Li X, Tian F, Wang F (2013) Rheumatoid arthritis-associated MicroRNA-155 targets SOCS1 and upregulates TNF-α and IL-1β in PBMCs. Int J Mol Sci 14:23910–23921CrossRef Li X, Tian F, Wang F (2013) Rheumatoid arthritis-associated MicroRNA-155 targets SOCS1 and upregulates TNF-α and IL-1β in PBMCs. Int J Mol Sci 14:23910–23921CrossRef
33.
Zurück zum Zitat Ravelli A, Martini A (2007) Juvenile idiopathic arthritis. Lancet 369:767–778CrossRef Ravelli A, Martini A (2007) Juvenile idiopathic arthritis. Lancet 369:767–778CrossRef
34.
Zurück zum Zitat Filkova M, Aradi B, Senolt L et al (2014) Association of circulating miR-223 and miR-16 with disease activity in patients with early rheumatoid arthritis. Ann Rheum Dis 73:1898–1904CrossRef Filkova M, Aradi B, Senolt L et al (2014) Association of circulating miR-223 and miR-16 with disease activity in patients with early rheumatoid arthritis. Ann Rheum Dis 73:1898–1904CrossRef
35.
Zurück zum Zitat Xia Z, Liu F, Zhang J et al (2015) Decreased expression of MiRNA-204-5p contributes to glioma progression and promotes glioma cell growth, migration and invasion. PLoS One 10:132399 Xia Z, Liu F, Zhang J et al (2015) Decreased expression of MiRNA-204-5p contributes to glioma progression and promotes glioma cell growth, migration and invasion. PLoS One 10:132399
Metadaten
Titel
Evaluation of plasma microRNA expressions in patients with juvenile idiopathic arthritis
verfasst von
Ferhat Demir
Alper Han Çebi
Mukaddes Kalyoncu
Publikationsdatum
31.08.2018
Verlag
Springer London
Erschienen in
Clinical Rheumatology / Ausgabe 12/2018
Print ISSN: 0770-3198
Elektronische ISSN: 1434-9949
DOI
https://doi.org/10.1007/s10067-018-4277-x

Weitere Artikel der Ausgabe 12/2018

Clinical Rheumatology 12/2018 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Notfall-TEP der Hüfte ist auch bei 90-Jährigen machbar

26.04.2024 Hüft-TEP Nachrichten

Ob bei einer Notfalloperation nach Schenkelhalsfraktur eine Hemiarthroplastik oder eine totale Endoprothese (TEP) eingebaut wird, sollte nicht allein vom Alter der Patientinnen und Patienten abhängen. Auch über 90-Jährige können von der TEP profitieren.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Bei schweren Reaktionen auf Insektenstiche empfiehlt sich eine spezifische Immuntherapie

Insektenstiche sind bei Erwachsenen die häufigsten Auslöser einer Anaphylaxie. Einen wirksamen Schutz vor schweren anaphylaktischen Reaktionen bietet die allergenspezifische Immuntherapie. Jedoch kommt sie noch viel zu selten zum Einsatz.

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

25.04.2024 Hypertonie Nachrichten

Beginnen ältere Männer im Pflegeheim eine Antihypertensiva-Therapie, dann ist die Frakturrate in den folgenden 30 Tagen mehr als verdoppelt. Besonders häufig stürzen Demenzkranke und Männer, die erstmals Blutdrucksenker nehmen. Dafür spricht eine Analyse unter US-Veteranen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.